REFERENCES

1. Ali A and Nayak DP.( 2000). Assembly of Sendai virus: M protein interacts with F and HN proteins and with the cytoplasmic tail and transmembrane domain of F protein. Virology. 276(2): 289-303.

2. Andrewes CH, Bang FB, and Burnet FM (1955) A short description of the myxovirus group (influenza and related viruses). Virology 1: 176-184.

3. Avalos RT, Yu Z, and Nayak DP.( 1997). Association of influenza virus NP and M1 proteins with cellular cytoskeletal elements in influenza virus-infected cells . J Virol. 71(4 ):2947-58.

4. Barbey- Martin C, Gigant B, Bizebard T, Calder LJ, Wharton SA, Skehel JJ, and Knossow M. (2002) An antibody that prevents the hemagglutinin low pH fusogenic transition. Virology. 294(1): 70-4.

5. Bentz J and Mittal A. (2000). Deployment of membrane fusion protein domains during fusion. Cell Biology International 24(11): 819-838.

6. Bentz J. (2000 ) Minimal aggregate size and minimal fusion unit for the first fusion pore of influenza hemagglutinin-mediated membrane fusion. Biophys J. 78(1): 227-45.

7. Beroza P, Fredkin DR, Okamura MY, and Feher G. (1991). Protonation of interacting residues in a protein by a Monte Carlo method: application to lysozyme and the photosynthetic reaction center of Rhodobacter sphaeroides. Proc Natl Acad Sci U S A . 88(13): 5804-8.

8. Bizebard T, Gigant B, Rigolet P, Rasmussen B, Diat O, Bosecke P, Wharton SA, Skehel JJ, and Knossow M. (1995) Structure of influenza virus haemagglutinin complexed with a neutralizing antibody. Nature. 376(6535): 92-4.

9. Blumenthal R, Sarkar DP, Durell S, Howard DE, and Morris SJ.(1996). Dilation of the influenza hemagglutinin fusion pore revealed by the kinetics of individual cell-cell fusion events. J Cell Biol. 135(1):63-71.

10. Boettcher C, Ludwig K, Herrmann A, Heel VM, and Stark K.( 1999). Structure of in£uenza haemagglutinin at neutral and at fusogenic pH by electron cryo-microscopy. FEBS Lett.463: 255-259.

11. Boulay F, Doms RW, Webster RG, and Helenius A. (1988). Posttranslational oligomerisation and cooperative acid activation of mixed influenza hemagglutinin trimers. The Journal of Cell Biology.106: 629-639.

12. Bui M, Whittaker G, and Helenius A. (1996) Effect of M1 protein and low pH on nuclear transport of influenza virus ribonucleoproteins. J Virol. 70(12):8391-401.

13. Bullough PA, Hughson FM, Skehel JJ, and Wiley DC (1994). Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371, 37-43.

14. Carr CM and Kim PS. (1993). A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell 73(4):823-32.

15. Carr CM, Chaudhry C, and Kim PS (1997) Influenza hemagglutinin is spring-loaded by a metastable native conformation. Proc Natl Acad Sci U S A. 94 (26): 14306-13.

16. Chen J, Skehel JJ and Wiley DC (1999). N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil. Proc Natl Acad Sci U S A. 96(16):8967-72.

17. Chen J, Wharton SA, Weissenhorn W, Calder LJ, Hughson FM, Skehel JJ, and Wiley DC. (1995). A soluble domain of the membrane-anchoring chain of influenza virus hemagglutinin (HA2) folds in Escherichia coli into the low-pH-induced conformation. Proc Natl Acad Sci U S A 92(26):12205-9.

18. Chen, J, Lee KH, Steinhauer DA, Stevens DJ, Skehel JJ, and Wiley DC. (1998). Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell 95:409–417.

19. Chernomordik LV, Leikina E, Kozlov MM, Frolov VA, and Zimmerberg, (1999) Structural intermediates in influenza haemagglutinin-mediated fusion. J. Mol. Membr. Biol. 16,33-42.

20. Chernomordik LV, Frolov VA, Leikina E, Bronk P, and Zimmerberg J (1998).The pathway of membrane fusion catalyzed by influenza hemagglutinin: restriction of lipids, hemifusion, and lipidic fusion pore formation. J Cell Biol. 140(6):1369-82.

21. Clague MJ, Schoch C, and Blumenthal R. (1991). Delay time for influenza virus hemagglutinin-induced membrane fusion depends on hemagglutinin surface density. J Virol. 65(5): 2402-7.

22. Colman PM and Lawrence MC. (2003). The structural biology of type I viral membrane fusion. Nat Rev Mol Cell Biol. 4(4):309-19.

23. Copeland CS, Doms RW, Bolzau EM, Webster RG, and Helenius A. (1986). Assembly of influenza hemagglutinin trimers and its role in intracellular transport. The Journal of Cell Biology. 103: 1179-1191.

24. Copeland, C. S., K. P. Zimmer, K. R. Wagner, G. A. Healey, I. Mellman, and A. Helenius. ( 1988). Folding, trimerization, and transport are sequential events in the biogenesis of influenza virus hemagglutinin. Cell . 53:197-209.

25. Cross KJ, Wharton SA, Skehel JJ, Wiley DC, and Steinhauer DA. (2001). Studies on influenza haemagglutinin fusion peptide mutants generated by reverse genetics. EMBO J; 20(16):4432-42 .

26. Dalit Bechor and Nir Ben-Tal (2001). Implicit solvent model studies of the interactions of the influenza hemagglutinin fusion peptide with lipid bilayers. Biophysical Journal 80: 643–655

27. Danieli T, Pelletier SL, Henis YI, and White JM. (1996). Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers. J Cell Biol 133(3):559-69.

28. Daniels RS, Downie JC, Hay AJ, Knossow M, Skehel JJ, Wang ML, and Wiley DC. (1985) Fusion mutants of the influenza virus hemagglutinin glycoprotein. Cell. 40(2): 431-9.

29. Epand RM (2003). Fusion peptides and the mechanism of viral fusion. Biochim Biophys Acta. 1614(1 ):116-21.

30. Epand RM and Epand RF. (2002). Thermal denaturation of influenza virus and its relationship to membrane fusion. Biochem J 365: 841-8.

31. Fodor E, Palese P, Brownlee GG, and Garcia-Sastre A (1998). Attenuation of influenza A virus mRNA levels by promoter mutations. J Virol. 72(8): 6283-90.

32. Geiss GK, Salvatore M, Tumpey TM, Carter VS, Wang X, Basler CF, Taubenberger JK, Bumgarner RE, Palese P, Katze MG, and Garcia-Sastre A. (2002) Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc Natl Acad Sci U S A. 99(16):10736-41

33. Gething MJ, Doms RW, York D, and White JM. (1986). Studies on the mechanism of membrane fusion: site-specific mutagenesis of the hemagglutinin of influenza virus. J Cell Biol ; 102(1): 11-23.

34. Godley L, Pfeifer J, Steinhauer D, Ely B, Shaw G, Kaufmann R, Suchanek E, Pabo C, Skehel JJ, Wiley DC, and Wharton S. (1992) Introduction of intersubunit disulfide bonds in the membrane-distal region of the influenza hemagglutinin abolishes membrane fusion activity. Cell. 21; 68(4): 635-45

35. Gomez-Puertas P, Albo C, Perez-Pastrana E, Vivo A, and Portela A. (2000) Influenza virus matrix protein is the major driving force in virus budding. J Virol. 74(24):11538-47.

36. Gray C and Tamm LK (1997). Structural studies on membrane-embedded influenza hemagglutinin and its fragments. Protein Science 6: 1993-2006.

37. Gray C, Tamm LK (1998) pH-induced conformational changes of membrane-bound influenza hemagglutinin and its effect on target lipid bilayers. Protein Sci. 7(11):2359-73.

38. Gruenke JA, Armstrong RT, Newcomb WW, Brown JC, and White JM. (2002).New insights into the spring-loaded conformational change of influenza virus hemagglutinin. Journal of Virology 76(9):4456-66.

39. Han X, Steinhauer DA, Wharton SA, and Tamm LK. (1999). Interaction of mutant influenza virus hemagglutinin fusion peptides with lipid bilayers: probing the role of hydrophobic residue size in the central region of the fusion peptide. Biochemistry 38 (45):15052-9.

40. Hernandez LD, Hoffman LR, Wolfsberg TG, and White JM (1996).Virus-cell and cell-cell fusion. Annu Rev Cell Dev Biol 12:627-61.

41. Hoffmann LR, Kuntz ID, and White JM. (1997). Structure based identification of an inducer of the low pH conformational change in the influenza virus hemagglutinin: irreversible inhibition of infectivity. Journal of Virology 71(11) 8808-8820.

42. Huang Q, Opitz R, Knapp E-W, and Herrmann A. (2002). Protonation and stability of the globular domain of influenza virus hemagglutinin. Biophysical Journal 82: 1050-1058.

43. Huang Q, Sivaramakrishna RP, Ludwig K, Korte T, Bottcher C, and Herrmann A (2003) Early steps of the conformational change of influenza virus hemagglutinin to a fusion active state: stability and energetics of the hemagglutinin. Biochim Biophys Acta. 1614(1): 3-13.

44. Jackson HC, Roberts N,. Wang ZM, and Belshe R. (2000). Management of influenza: use of new antivirals and resistance in perspective. Clin. Drug Investig. 20:447–454.

45. Jahn R and Sudhof TC. (1999).Membrane fusion and exocytosis . Annu Rev Biochem; 68:863-911.

46. Jones S and Thorton JM (1996). Principles of protein-protein interactions. Proc. Natl. Acad. Sci. USA 93, 13-20.

47. Kelly ML, Cook JA, Brown-Augsburger P, Heinz BA, Smith MC, and Pinto LH. (2003). Demonstrating the intrinsic ion channel activity of virally encoded proteins. FEBS Lett. 552(1):61-7.

48. Kemble GW, Bodian DL, Rose J, Wilson IA, and White JM. (1992) Intermonomer disulfide bonds impair the fusion activity of influenza virus hemagglutinin. J Virol . 66(8): 4940-50.

49. Kemble GW, Danieli T, and White JM. (1994) Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion. Cell. 76(2):383-91.

50. Klenk HD and Garten W. 1994. Host cell proteases controlling virus pathogenecity. Trends Microbiol. 2: 39–43.

51. Korte T, Ludwig K, Booy FP, Blumenthal R, and Herrmann A. (1999 ). Conformational intermediates and fusion activity of influenza virus hemagglutinin. Journal of Virology 73: 4567-4574.

52. Kozerski C, Ponimaskin E, Schroth-Diez B, Schmidt MF, and Herrmann A. (2000) Modification of the cytoplasmic domain of influenza virus hemagglutinin affects enlargement of the fusion pore . J Virol. 74(16):7529-37.

53. Kozlov MM and Chernomordik LV. (1998). A mechanism of protein-mediated fusion: coupling between refolding of the influenza hemagglutinin and lipid rearrangements. Biophys J. 1998 Sep;75(3):1384-96.

54. Kumar S and Nussinov R. (2002) Close-range electrostatic interactions in proteins. Chembiochem . 3(7 ):604-17.

55. Lamb RA and Krug RM. (2001). Orthomyxoviridae: the viruses and their replication. In: Knipe, D.M., Howley, P.M. (Eds.), Fields Virology, 4th ed. Lippincott Williams and Wilkins, Philadelphia, pp. 1487–1532.

56. Lamb RA, Holsinger L.J, and Pinto LH. (1994). Receptor-Mediated Virus Entry into Cells (Wimmer,E.,Ed.),pp.303-321, Cold Spring Harbor Laboratory Press,Cold Spring Harbor,NY.

57. Larsen TA, Olson AJ, Goodsell DS.( 1998).Morphology of protein-protein interfaces. Structure. 15;6(4):421-7.

58. Li Y, Han X, and Tamm LK. (2003).Thermodynamics of fusion peptide-membrane interactions . Biochemistry. Jun 17;42(23):7245-51.

59. Lindau M and Almers W. (1995).Structure and function of fusion pores in exocytosis and ectoplasmic membrane fusion. Curr Opin Cell Biol. Aug;7(4):509-17.

60. Maley F, Trimble RB, Tarentino AL, and Plummer TH Jr. (1989). Characterization of lycoproteins and their associated oligo- saccharides through the use of endoglycosidases . Anal. Biochem. 180, 195–204

61. Marqusee S and Sauer RT. (1994) Contributions of a hydrogen bond/salt bridge network to the stability of secondary and tertiary structure in lambda repressor. Protein Sci. 3(12):2217-25.

62. Monto AS (2003). The role of antivirals in the control of influenza. Vaccine. (2003) May 1;21(16):1796-800.

63. Musafia B, Buchner V, and Arad D. (1995) Complex salt bridges in proteins: statistical analysis of structure and function . J Mol Biol. 254(4):761-70.

64. Neumann G, Hughes MT, and Kawaoka Y. (2000) Influenza A virus NS2 protein mediates vRNP nuclear export through NES-independent interaction with hCRM1. EMBO J. 19(24):6751-8.

65. Nicholson KG, Wood JM, and Zambon M. (2003) Influenza. Lancet. 362(9397):1733-45.

66. O'Neill RE and Palese P. (1995). NPI-1, the human homolog of SRP-1, interacts with influenza virus nucleoprotein. Virology.206(1):116-25.

67. Oxford JS and Lambkin R. (1998). Targeting influenza virus neuraminidase - a new strategy for antiviral therapy. Drug Discov. Today 3:448–456.

68. Proesch S, Heider H, Schroeder C, Shilov AA, Sinitzyn BV, Blinov VM, Krueger DH, and Froemmel C (1990). Mapping mutations in influenza A virus resistant to norakin . FEBS 267 (1): 19-21.

69. Puri A, Booy FP, Doms RW, White JM, and Blumenthal R (1990). Conformational changes and fusion activity of influenza virus hemagglutinin of the H2 and H3 subtypes: effects of acid pretreatment . J.Virol 64: 10108-10113.

70. Qiao H, Armstrong RT, Melikyan GB, Cohen FS, and White JM. (1999). A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype. Mol Biol Cell; 10(8):2759-69.

71. Remeta DP, Krumbiegel M, Minetti CA, Puri A, Ginsburg A, and Blumenthal R. (2002). Acid-induced changes in thermal stability and fusion activity of influenza hemagglutinin. Biochemistry. 41(6 ): 2044-54.

72. Ruigrok RW, Wrigley NG, Calder LJ, Cusack S, Wharton SA, Brown EB, and Skehel JJ. (1986) Electron microscopy of the low pH structure of influenza virus haemagglutinin. EMBO J 5(1): 41-9.

73. Sambrook J, Fritsch E, and Maniatis T (1989). Molecular cloning: a laboratory manual, 2 nd edition, COld Spring harbor, N.Y.

74. Sauter NK, Glick GD, Crowther RL, Park S-J, Eisen MB, Skehel JJ, Knowles JR, and Wiley DC. (1992 ). Crystallographic detection of a second ligand binding site in the influenza hemagglutinin. Proc.Natl.Acad.Sci.USA . 89: 324-328.

75. Shangguan T, Siegel DP, Lear JD, Axelsen PH, Alford D, and Bentz J (1998). Morphological changes and fusogenic activity of influenza virus hemagglutinin. Biophys J. 1998 Jan;74(1):54-62.

76. Sheinerman FB, Norel R, Honig B.( 2000). Electrostatic aspects of protein-protein interactions. Curr Opin Struct Biol . 10(2): 153-9.

77. Skehel JJ and Wiley DC. (2000). Receptor binding and membrane fusion in virus entry: The Influenza Hemagglutinin. Ann. Rev. Biochem. 69:531-69.

78. Skehel JJ and Wiley DC.(1998). Coiled coils in both intracellular vesicle and viral membrane fusion. Cell. 95(7):871-4.

79. Skehel JJ, Bayley PM, Brown EB, Martin SR, Waterfield MD, White JM, Wilson IA, and Wiley DC. (1982) Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc Natl Acad Sci U S A. 79(4): 968-72.

80. Staschke KA, Hatch SD, Tang JC, Hornback WJ, Munroe JE, Colacino JM, and Muesing MA. (1998). Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid. Virology. 248, 264-274.

81. Stegmann T, Booy FP, and Wilschut J. (1987) Effects of low pH on influenza virus. Activation and inactivation of the membrane fusion capacity of the hemagglutinin . J Biol Chem. 262(36): 17744-9.

82. Stegmann T, Morselt HWM, Booy FP, van Breemen JFL, Scerphof G, and Wilschut J. (1987). Functional reconstitution of influenza virus enveloped. EMBO J. 6:2651-2659.

83. Stegmann T, White JM, and Helenius A. (1990) Intermediates in influenza induced membrane fusion. EMBO J. 9(13): 4231-41.

84. Steinhauer DA and Skehel JJ. (2002) Genetics of influenza viruses. Annu Rev Genet. 36:305-32. Epub 2002 Jun 11.

85. Suomalainen M (2002). Lipid Rafts and Assembly of Enveloped Viruses. Traffic 3(10): 697-762

86. Tamm LK (2003) Hypothesis: spring-loaded boomerang mechanism of influenza hemagglutinin-mediated membrane fusion. Biochim Biophys Acta. 11;1614(1):14-23.

87. Tatu U and Helenius A (1997 ). Interactions between newly synthesized glycoproteins, calnexin and a network of resident chaperones in the endoplasmic reticulum. J Cell Biol. 136(3):555-65.

88. Tatulian SA and Tamm LK (2000) Secondary structure, orientation, oligomerization, and lipid interactions of the transmembrane domain of influenza hemagglutinin. Biochemistry.25;39(3):496-507.

89. Tatulian SA and Tamm LK. (1996) Reversible pH-dependent conformational change of reconstituted influenza hemagglutinin. J Mol Biol. 1996 Jul 19;260(3):312-6.

90. Tse FW, Iwata A, and Almers W. (1993). Membrane flux through the pore formed by a fusogenic viral envelope protein during cell fusion. J Cell Biol. May;121(3):543-52.

91. Ullmann GM and Knapp EW. (1999). Electrostatic models for computing protonation and redox equilibria in proteins. Eur Biophys J. 28(7):533-51.

92. Varghese JN, and. Colman PM. (1991). Three-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2.2 A resolution . J. Mol. Biol. 221:473–486.

93. Varghese JN, Epa VC, and Colman PM. (1995). Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase. Protein Sci. 4: 1081–1087.

94. Ward AC, Castelli LA, Lucantoni AC, White JF, Azad AA, and Macreadie IG. (1995) Expression and analysis of the NS2 protein of influenza A virus. Arch Virol. 140(11):2067-73.

95. Watanabe K, Handa H, Mizumoto K, and Nagata K. (1996). Mechanism for inhibition of infuenza virus RNA polymerase activity by matrix protein . J. Virol. 70, 241-247.

96. Wedekind JE, Trame CB, Dorywalska M, Koehl P, Raschke TM, McKee M, FitzGerald D, Collier RJ, McKay DB.(2001). Refined crystallographic structure of Pseudomonas aeruginosa exotoxin A and its implications for the molecular mechanism of toxicity. J Mol Biol . 7;314(4):823-37.

97. White J, Helenius A, and Gething M-J. (1982). Hemagglutinin of influenza virus expressed from a cloned gene promotes membrane fusion. Nature (London) 300:658-659

98. White JM and Wilson IA (1987) Anti-peptide antibodies detect steps in a protein conformational change: low-pH activation of the influenza virus hemagglutinin. J Cell Biol. 105(6 Pt 2): 2887-96

99. Whittaker GR. (2001 ) Intracellular trafficking of influenza virus: clinical implications for molecular medicine. Exp. Rev. Mol. Med. 8 February, http://www-ermm.cbcu.cam.ac.uk/01002447h.htm

100. Wiley DC and Skehel JJ (1987) The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Ann.Rev.Biochem 56: 365-394.

101. Wilson IA, Skehel JJ, and Wiley DC. (1981) Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature. 289(5796): 366-73.

102. Wright PF and Webster RG. (2001). Orthomyxoviruses. In: Knipe, D.M., Howley, P.M. (Eds.), Fields Virology, 4th ed. Lippincott Williams and Wilkins, Philadelphia, pp. 1533–1579.

103. Xu D, Tsai CJ, and Nussinov R. (1997) Hydrogen bonds and salt bridges across protein-protein interfaces . Protein Eng. 10(9 ):999-1012.

104. Zhirnov OP, Ikizler MR, and Wright PF. (2002) Cleavage of influenza a virus hemagglutinin in human respiratory epithelium is cell associated and sensitive to exogenous antiproteases. J Virol. 76(17):8682-9.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
14.09.2006